相似文献
1
How Should We Classify Patients Who Have Spondylitis and Psoriasis?
J Korean Med Sci. 2022 Aug 22;37(33):e259. doi: 10.3346/jkms.2022.37.e259.
2
ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii108-9. doi: 10.1136/ard.2004.030858.
3
Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series.
Int J Rheum Dis. 2020 Mar;23(3):454-456. doi: 10.1111/1756-185X.13791. Epub 2020 Jan 15.
4
Paradoxical plaque psoriasis due to secukinumab treatment in an ankylosing spondylitis patient.
Dermatol Ther. 2020 Jul;33(4):e13504. doi: 10.1111/dth.13504. Epub 2020 Jun 4.
5
[Ankylosing spondyloarthritis and psoriasis].
Ter Arkh. 1982;54(6):103-6.
6
Comment on: Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Rheumatology (Oxford). 2021 Jan 5;60(1):e24-e25. doi: 10.1093/rheumatology/kez670.
7
Ankylosing spondylitis and the other seronegative spondylarthritides.
Compr Ther. 1979 Aug;5(8):41-7.
8
Ankylosing spondylitis, Reiter's syndrome, psoriatic arthritis, and arthritis of inflammatory bowel disease.
Prim Care. 1984 Jun;11(2):271-82.
9
Effects of guselkumab on ankylosing spondylitis-type pustulotic arthro-osteitis in a patient with palmoplantar pustulosis.
Dermatol Ther. 2020 Nov;33(6):e14088. doi: 10.1111/dth.14088. Epub 2020 Aug 18.
10
Extra-articular manifestations as markers of disease in seronegative spondylarthropathies.
Clin Exp Rheumatol. 1987;5 Suppl 1:S69-74.
本文引用的文献
1
Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy.
J Korean Med Sci. 2022 Aug 22;37(33):e253. doi: 10.3346/jkms.2022.37.e253.
2
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years.
RMD Open. 2022 Jan;8(1). doi: 10.1136/rmdopen-2021-001986.
3
Axial involvement in psoriatic arthritis: An update for rheumatologists.
Semin Arthritis Rheum. 2021 Aug;51(4):880-887. doi: 10.1016/j.semarthrit.2021.06.006. Epub 2021 Jun 19.
4
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
RMD Open. 2020 Feb;6(1). doi: 10.1136/rmdopen-2019-001149.
5
Spondylitis is the most common pattern of psoriatic arthritis in Korea.
Rheumatol Int. 2000;19(3):89-94. doi: 10.1007/s002960050109.
Zotero 插件